Status: Recruiting
Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy
interventional study of intravesical chemotherapy and sistemic immunotherapy in NMIBC
Participants needed: 37
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: BLATAMUpdated: May 28, 2026Locations: 1
Eligibility criteria
Be willing and able to provide documented informed consent for the trial. The su... [+9]
1. Has muscle-invasive (i.e. T2, T3, T4) locally advanced non-resectable or meta...